Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.

Journal of Clinical Microbiology
Wayne DimechElizabeth M Dax

Abstract

An evaluation of anti-rubella virus immunoglobulin G (IgG) immunoassays that report in international units per milliliter (IU/ml) was performed to determine their analytical performance and the degree of correlation of the test results. A total of 321 samples were characterized based on results from a hemagglutination inhibition assay. The 48 negative and 273 positive samples were used to determine the sensitivity and specificity of the assays. When equivocal results were interpreted as reactive, the sensitivity of the immunoassays ranged from 98.9 to 99.9% and the specificity ranged from 77.1 to 95.8%. All assays had positive and negative delta values of less than 2. A significant difference between the mean results of all assays was demonstrated by analysis of variance. However, post hoc analysis showed there was good correlation in the mean results expressed in IU/ml between some of the assays. Our results show the level of standardization between anti-rubella virus IgG immunoassays reporting results expressed as IU/ml has improved since a previous study in 1992, but further improvement is required.

References

Aug 1, 1991·Epidemiology and Infection·J E Cradock-Watson
Oct 1, 1988·Journal of Virological Methods·N CroftsI D Gust
Oct 1, 1987·American Journal of Public Health·S E RobertsonS R Preblud
Jun 12, 1982·The Medical Journal of Australia·B H FrancisL I Taft
Aug 1, 1996·American Journal of Clinical Pathology·L P Skendzel
Oct 27, 1999·Journal of Medical Microbiology·S O'SheaJ M Best
Dec 10, 1999·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·J NedeljkovicC Oker-Blom
May 1, 2001·Clinical and Diagnostic Laboratory Immunology·F VlaspolderR J Diepersloot
May 12, 2001·Vaccine·S A Plotkin
Jul 20, 2002·BMJ : British Medical Journal·Jennifer M BestGisela Enders
Feb 12, 2004·Revista Panamericana De Salud Pública = Pan American Journal of Public Health·Susan E RobertsonBradley S Hersh
Apr 6, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Francesco DatiJosef van Helden
Apr 6, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·David Okrongly
Apr 10, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Cheng-Hsien ChangRobert Anderson
Mar 9, 2006·Clinical and Vaccine Immunology : CVI·Kim M WilsonElizabeth M Dax
Nov 1, 2006·American Journal of Clinical Pathology·William E OwenWilliam L Roberts
Mar 6, 2007·Seminars in Fetal & Neonatal Medicine·Jennifer M Best

❮ Previous
Next ❯

Citations

Aug 18, 2010·Viral Immunology·Nicholas P GreenwoodGregory A Poland
Nov 24, 2012·Clinical and Vaccine Immunology : CVI·A R CentonzeR Fontana
Dec 21, 2012·Clinical and Vaccine Immunology : CVI·Wayne DimechKim Wilson
Jan 25, 2013·Clinical and Vaccine Immunology : CVI·Martin EndersGisela Enders
Dec 8, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Daniela HuzlyMarcus Panning
Dec 27, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Marcel MiedougeJacques Izopet
Jun 3, 2014·American Journal of Obstetrics and Gynecology·Jill HuttonMelanie Mouzoon
Jun 25, 2016·Vaccine·Wayne Dimech, Mick N Mulders
Aug 24, 2010·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Giuseppe PortellaUNKNOWN Multicenter Italian Group for Hospital ToRC evaluation
Jun 13, 2017·Human Vaccines & Immunotherapeutics·Megan K YoungAllan W Cripps
Jan 7, 2014·Clinical and Vaccine Immunology : CVI·Nathaniel D LambertGregory A Poland
Nov 27, 2015·Clinical Microbiology Reviews·Wayne DimechChristelle Vauloup-Fellous
May 6, 2016·Journal of Clinical Microbiology·Elise BouthryChristelle Vauloup-Fellous
Mar 9, 2017·BMC Infectious Diseases·Maria Serena GalloneSilvio Tafuri
Jun 8, 2017·Memórias do Instituto Oswaldo Cruz·Priscila T BaschirottoLeonardo Foti
Dec 15, 2020·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·E BouthryC Vauloup-Fellous
Sep 11, 2019·The Lancet Infectious Diseases·Sarah L KempsterC Micha Nübling
Feb 4, 2019·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·O PiconeC Vauloup-Fellous

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Robert EichlerHeike Christ
Lancet
J E Banatvala, D W G Brown
© 2022 Meta ULC. All rights reserved